Stryker (SYK) Stock
Key stats
- Market cap
- $121.36B
- Price / Earnings ratio
- 34.1x
- EPS (TTM)
- $9.46
- Volume
- Loading
- 52-week high
- $389.33
- 52-week low
- $267.00
- Dividend yield
- 1.10%
- Dividend amount (latest)
- $0.88
- EPS vs analyst estimate
- +1.6%Q3 FY25 · $3.19 vs $3.14
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with SYK
Recent news

SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook Cut
SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook Cut
SYK

SYK Q3 Earnings Call Highlights Softer Demand and Revised Outlook
SYK Q3 Earnings Call Highlights Softer Demand and Revised Outlook
SYK

What Stryker (SYK) Said on Its Q3 Earnings Call
What Stryker (SYK) Said on Its Q3 Earnings Call
SYK

Stryker's Guidance Cut Rattles Investors: What It Really Says About 2027
Stryker's Guidance Cut Rattles Investors: What It Really Says About 2027
SYK
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 56.57
- MACD 12/26/9
- 9.31
- EMA 9 of MACD
- 7.98
- MACD histogram
- 1.33
- SMA 50
- $292.21
- Price above SMA 50
- EMA 50
- $304.26
- Price above EMA 50
- SMA 200
- $322.38
- Price below SMA 200
- EMA 200
- $321.55
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 14 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $3.58 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook Cut
SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook Cut
SYK

SYK Q3 Earnings Call Highlights Softer Demand and Revised Outlook
SYK Q3 Earnings Call Highlights Softer Demand and Revised Outlook
SYK

What Stryker (SYK) Said on Its Q3 Earnings Call
What Stryker (SYK) Said on Its Q3 Earnings Call
SYK

Stryker's Guidance Cut Rattles Investors: What It Really Says About 2027
Stryker's Guidance Cut Rattles Investors: What It Really Says About 2027
SYK

Stryker (SYK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Stryker (SYK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
SYK

Stryker (SYK) Q3 Earnings and Revenues Lag Estimates
Stryker (SYK) Q3 Earnings and Revenues Lag Estimates
SYK

SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?
SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?
SYK

Countdown to Stryker (SYK) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Countdown to Stryker (SYK) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
SYK

Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
SYK

PAHC or SYK: Which Is the Better Value Stock Right Now?
PAHC or SYK: Which Is the Better Value Stock Right Now?
SYK
News tone: automated (AI) classification of the article's content, not a price prediction.
About Stryker
Stryker is one of the world’s leading medical technology companies and, together with our customers, is driven to make healthcare better. We offer innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Kevin A. Lobo | Chairman & CEO | 1965 |
| Mr. Preston W. Wells | VP & CFO | 1977 |
| Mr. Viju S. Menon | Group President of Global Quality & Operations | 1968 |
| Mr. J. Andrew Pierce | Group President of MedSurg & Neurotechnology | 1974 |
| Ms. Emily Baculik | VP, Chief Accounting Officer & Corporate Controller | 1980 |
| Mr. Robert C. Cohen | CTO and VP of Global R&D - Joint Replacement | — |
| Ms. Debra S. King | VP and Chief Digital & Information Officer | 1972 |
| Mr. Nick Mead | Vice President of Investor Relations | — |
| Mr. Robert S. Fletcher | VP & Chief Legal Officer | 1971 |
| Ms. Dana S. McMahon | VP & Chief Compliance Officer | — |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 56.57
- MACD 12/26/9
- 9.31
- EMA 9 of MACD
- 7.98
- MACD histogram
- 1.33
- SMA 50
- $292.21
- Price above SMA 50
- EMA 50
- $304.26
- Price above EMA 50
- SMA 200
- $322.38
- Price below SMA 200
- EMA 200
- $321.55
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
14 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $290.00
- Average
- $334.71
- High
- $390.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -9.6 | +11.8 | ||||||||||
| 2022 | -7.6 | +5.9 | +1.8 | -10.3 | -1.0 | -12.7 | +5.3 | -3.9 | -2.0 | +9.2 | +6.3 | +1.5 |
| 2023 | +3.2 | -5.8 | +9.8 | +4.2 | -8.1 | +9.5 | -4.9 | +1.5 | -3.9 | -1.3 | +8.9 | +0.6 |
| 2024 | +13.2 | +2.5 | +1.3 | -5.1 | +4.0 | +0.3 | -2.7 | +8.2 | +0.5 | -0.3 | +6.8 | -7.6 |
| 2025 | +9.1 | -1.3 | -5.7 | +0.2 | +2.3 | +3.9 | -1.0 | +3.6 | -5.2 | -2.2 | +3.6 | -5.6 |
| 2026 | +6.1 | +5.2 | -15.1 | -4.3 | +3.5 | +5.1 | +3.9 | -5.1 | -13.2 | +6.9 | +3.9 |
Corporate actions
Upcoming
No upcoming corporate actions for SYK



